VivoSeq
Other

Radiofrequency Ablation

0

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

Radiofrequency Ablation is an early-stage landscape with 0 programs across 1 company. The most active players are Takeda.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Takeda logo

Takeda

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

18

clinical trials

Completed10 · 56%
Unknown status4 · 22%
Terminated2 · 11%
Not yet recruiting1 · 6%
Active, not recruiting1 · 6%

Clinical Trials

Trial Activity

18 trials

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
Active, not recruiting·National Cancer Institute (NCI)·Phase 2·NCT02521285·21 enrolled
Comparison of Ganglion Impar Radiofrequency Ablation and Phenol Neurolysis Techniques for Chronic Coccydynia Treatment
Not yet recruiting·MMarmara University·N/A·NCT07021365·30 enrolled
Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer
Completed·IInstitut Bergonié·Phase 2·NCT00712712·78 enrolled
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Completed·—·Phase 2·NCT00813293·20 enrolled
Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study
Completed·WWestern University, Canada·N/A·NCT02335190·31 enrolled
Pregabalin Versus Pulsed Radiofrequency Ablation for Treatment of Chronic Post-thoracotomy Pain
Completed·MMansoura University·N/A·NCT03942796·30 enrolled
Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
Completed·National Institutes of Health Clinical Center (CC)·Phase 1·NCT00093444·30 enrolled
Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy
Completed·TTaipei Medical University WanFang Hospital·Phase 4·NCT04707547·5 enrolled
A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver
Completed·IImunon·Phase 1·NCT00441376·30 enrolled
Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
Completed·UUniversity of California, Davis·N/A·NCT00584402·8 enrolled
Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours
Completed·UUppsala University Hospital·Phase 4·NCT02016391·50 enrolled
Sidekick vs Conventional Cannula in Lumbar Medial Branch Radiofrequency Ablation
Completed·SSaglik Bilimleri Universitesi Gulhane Tip Fakultesi·N/A·NCT07475689·82 enrolled
Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
Terminated·Takeda logoTakeda·Phase 2·NCT02162758·6 enrolled
Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation
Terminated·JJohns Hopkins University·Phase 4·NCT03247413·63 enrolled
EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy
Unknown status·TThe University of Hong Kong·Phase 4·NCT04809935·54 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)